Skip to main content
. 2012 Aug 10;1(3):88–94. doi: 10.1016/j.jbo.2012.07.002

Fig. 5.

Fig. 5

Course of PSA levels in patients with PC. Mean PSA levels steadily decreased during ZOL therapy in patients with PC, but were increased at the final 1-year follow-up. PC, prostate cancer; PSA, prostate-specific antigen; ZOL, zoledronic acid.